Part 2 – Beyond the Pandemic : Strengthening access to COVID-19 therapies for high risk patients in England

Beyond the pandemic – Strengthening access to Covid-19 therapies for high-risk patients in England – September 2025 – FINA

Despite significant evolution in national policy toward endemic COVID-19 management, access to COVID-19 treatments for high-risk patients remains inconsistent across England. This report – based on Kintiga’s original policy analysis and reinforced through qualitative interviews with key stakeholders – highlights the enduring disparities across England and proposes pragmatic recommendations for actions at both national and local levels.